Mismatch repair protein and MLH1 methylation status as predictors of response to adjuvant therapy in endometrial cancer

Lignende værker

• Adjuvant Therapy for Endometrial Cancer in the Era of Molecular Classification
  af: Sumedha Gupta, et al.
  Udgivet: (2024-10-01)
• Functional implications of the p.Cys680Arg mutation in the MLH1 mismatch repair protein
  af: Mev Dominguez‐Valentin, et al.
  Udgivet: (2014-07-01)
• Screening of Lynch syndrome in endometrial cancer in Iranian population with mismatch repair protein by immunohistochemistry
  af: Somayyeh Noei Teymoordash, et al.
  Udgivet: (2022-09-01)
• Performance of the Idylla microsatellite instability test in endometrial cancer
  af: Marta Mendiola, et al.
  Udgivet: (2024-10-01)
• Germline MLH1 and MSH6 mutations from two Lynch syndrome families identified in a patient with early-onset of endometrial cancer: A case report
  af: Yi-Ching Huang, et al.
  Udgivet: (2024-06-01)